The neurohumoral axis in congestive heart failure.
暂无分享,去创建一个
J. Cohn | T. Levine | G. Francis | S. Goldsmith | M. Olivari | G. Francis
[1] J. Oates,et al. Comparative Assessment of Stimuli That Release Neuronal and Adrenomedullary Catecholamines in Man , 1979, Circulation.
[2] J. Cohn,et al. Impaired response of plasma vasopressin to orthostatic stress in patients with congestive heart failure. , 1983, Journal of the American College of Cardiology.
[3] E. Michelson,et al. Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac death. , 1980, Annals of internal medicine.
[4] S. Downing,et al. Ventricular function in norepinephrine-induced cardiomyopathic rabbits. , 1982, The American journal of physiology.
[5] R. Cody,et al. Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure. , 1983, The American journal of medicine.
[6] A. A. Taylor,et al. Propylbutyldopamine: Hemodynamic Effects in Conscious Dogs, Normal Human Volunteers and Patients with Heart Failure , 1983, Circulation.
[7] Garrett Lee,et al. Abnormalities in the regional circulations accompanying congestive heart failure. , 1975, Progress in cardiovascular diseases.
[8] J. Cohn,et al. The Neurohumoral and Hemodynamic Response to Orthostatic Tilt in Patients with Congestive Heart Failure , 1983, Circulation.
[9] B. R. Macdonald,et al. Antihypertensive activity of LY141865, a selective presynaptic dopamine receptor agonist. , 1983, The Journal of pharmacology and experimental therapeutics.
[10] E. Braunwald,et al. Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure. , 1981, The American journal of medicine.
[11] R. Tarazi,et al. Renin, aldosterone and cardiac decompensation: studies with an oral converting enzyme inhibitor in heart failure. , 1979, The American journal of cardiology.
[12] E. Braunwald,et al. Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure. , 1963, The American journal of medicine.
[13] R. Cody,et al. Plasma and Platelet Vasopressin in Essential Hypertension and Congestive Heart Failure , 1983, Hypertension.
[14] J. Cohn,et al. Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. , 1982, American heart journal.
[15] J. Cohn,et al. Hemodynamic effects of trimazosin in patients with left ventricular failure , 1978, Clinical pharmacology and therapeutics.
[16] R. Miller,et al. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. , 1977, The New England journal of medicine.
[17] L. Getzen,et al. Cardiac arrhythmias and cardiomyopathy associated with pheochromocytomas. Report of three cases. , 1967, American journal of surgery.
[18] J. Cohn,et al. Acute and Long‐term Response to an Oral Converting‐enzyme Inhibitor, Captopril, in Congestive Heart Failure , 1980, Circulation.
[19] J. Cohn,et al. Regional blood flow response to orthostasis in patients with congestive heart failure. , 1983, Journal of the American College of Cardiology.
[20] J. Cohn,et al. Role of the Renin-Angiotensin System in the Systemic Vasoconstriction of Chronic Congestive Heart Failure , 1978, Circulation.
[21] N. Hollenberg,et al. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. , 1980, The New England journal of medicine.
[22] L. Share. Interrelations between vasopressin and the renin-angiotensin system. , 1979, Federation proceedings.
[23] J. Cohn,et al. The effects of bromocriptine in patients with congestive heart failure. , 1983, American heart journal.
[24] L. Hillis,et al. Propylhexedrine-induced left ventricular dysfunction. , 1982, Annals of internal medicine.
[25] N. Reichek,et al. Long-term vasodilator therapy with trimazosin in chronic cardiac failure. , 1980, The New England journal of medicine.
[26] Clark Bj. Dopamine receptors and the cardiovascular system. , 1981 .
[27] M. Dubocovich,et al. Physiological and Pharmacological Role of the Regulation of Noradrenaline Release by Presynaptic Dopamine Receptors in the Peripheral Nervous System , 1979 .
[28] J. Cohn,et al. Increased plasma arginine vasopressin levels in patients with congestive heart failure. , 1983, Journal of the American College of Cardiology.
[29] R. Falk,et al. Reduction in vulnerability to ventricular fibrillation by bromocriptine, a dopamine agonist. , 1981, Cardiovascular research.
[30] Y. Hirota,et al. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. , 1982, Japanese heart journal.
[31] D C Harrison,et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.
[32] J. Greenhouse,et al. Plasma Norepinephrine Variations with Dietary Sodium Intake , 1980, Hypertension.
[33] K. Swedberg,et al. PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE , 1979, The Lancet.
[34] T. Berl,et al. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. , 1981, The New England journal of medicine.
[35] G. Riegger,et al. Antidiuretic hormone in congestive heart failure. , 1982, The American journal of medicine.
[36] H. Langford,et al. Vasopressin Elevation in Essential Hypertension and Increased Responsiveness to Sodium Intake , 1981, Hypertension.
[37] J. W. Wilson,et al. 4-(Aminoalkyl)-7-hydroxy-2(3H)-indolones, a novel class of potent presynaptic dopamine receptor agonists. , 1983, Journal of medicinal chemistry.
[38] J. Cohn,et al. Abnormal neurohumoral response to nitroprusside infusion in congestive heart failure. , 1983, Journal of the American College of Cardiology.
[39] B. Brundage,et al. Immediate and Sustained Hemodynamic and Clinical Improvement in Chronic Heart Failure by an Oral Angiotensin‐converting Enzyme Inhibitor , 1980, Circulation.
[40] N. Dhalla,et al. Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy. , 1981, American heart journal.
[41] D. Mason,et al. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure. , 1981, American heart journal.
[42] C. W. Hartman,et al. Acute cardiomyopathy secondary to intravenous amphetamine abuse. , 1982, Annals of internal medicine.
[43] R. Schrier,et al. Vascular effects of arginine vasopressin during fluid deprivation in the rat. , 1981, The Journal of clinical investigation.
[44] I. Cavero,et al. Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents. Part I: Subclassification and functional description. , 1982, Life sciences.
[45] J. Cohn,et al. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. , 1982, The American journal of cardiology.
[46] D L Eckberg,et al. Defective cardiac parasympathetic control in patients with heart disease. , 1971, The New England journal of medicine.
[47] A. Weyman,et al. Plasma and Urinary Norepinephrine Values at Extremes of Sodium Intake in Normal Man , 1979, Hypertension.
[48] A. Cowley,et al. Evidence and Quantification of the Vasopressin Arterial Pressure Control System in the Dog , 1980, Circulation research.
[49] J. Cohn,et al. Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. , 1982, The American journal of cardiology.
[50] H. Sarau,et al. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist. , 1982, The Journal of pharmacology and experimental therapeutics.
[51] J. Laragh,et al. Mechanisms Governing the Postural Response and Baroreceptor Abnormalities in Chronic Congestive Heart Failure: Effects of Acute and Long‐term Converting‐enzyme Inhibition , 1982, Circulation.
[52] I. Shoulson,et al. Bromocriptine inhibits norepinephrine release , 1979, Clinical pharmacology and therapeutics.
[53] O. Deriaz,et al. Cardiac output distribution during vasopressin infusion or dehydration in conscious dogs. , 1982, The American journal of physiology.
[54] H. Gavras,et al. IMPROVEMENT OF CHRONIC CONGESTIVE HEART-FAILURE BY ORAL CAPTOPRIL , 1979, The Lancet.
[55] D. Sharpe,et al. LOW-DOSE CAPTOPRIL IN CHRONIC HEART FAILURE: ACUTE HAEMODYNAMIC EFFECTS AND LONG-TERM TREATMENT , 1980, The Lancet.
[56] L. I. Goldberg,et al. Peripheral dopamine receptors: A classification based on potency series and specific antagonism , 1983 .
[57] T. Ryan,et al. Angiotensin Converting Enzyme Inhibition in Patients with Congestive Heart Failure , 1978, Circulation.
[58] Robert Barrett,et al. Dopamine receptor agonists in cardiovascular therapy , 1983 .
[59] E. Braunwald,et al. MYOCARDIAL NOREPINEPHRINE CONCENTRATION IN MAN. EFFECTS OF RESERPINE AND OF CONGESTIVE HEART FAILURE. , 1963, The New England journal of medicine.
[60] R. Magorien,et al. Clonidine in congestive heart failure: a vasodilator with negative inotropic effects. , 1983, The American journal of cardiology.
[61] T. Levine,et al. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. , 1981, The American journal of cardiology.
[62] M. Vance,et al. Drugs Five Years Later: Bromocriptine , 1984 .
[63] E. Braunwald,et al. Long-term therapy of heart failure with prazosin: a randomized double blind trial. , 1980, The American journal of cardiology.
[64] J. A. Thomas,et al. Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.
[65] R. Cody,et al. Circulatory autoregulation in chronic congestive heart failure: responses to head-up tilt in 41 patients. , 1983, The American journal of cardiology.
[66] J. Cohn,et al. Elevated left ventricular myocardial dopamine in preterminal idiopathic dilated cardiomyopathy. , 1983, The American journal of cardiology.